Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand.

Trial Profile

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2013

At a glance

  • Drugs Hib-DTaP-poliovirus vaccine (Primary) ; DTaP poliovirus vaccine; Hepatitis B vaccine recombinant
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 04 Oct 2011 Last checked against ClinicalTrials.gov record (Booster trial: NCT01031303).
    • 04 Oct 2011 Last checked against ClinicalTrials.gov record (Booster trial: NCT01031303).
    • 15 Dec 2009 Planned number of patients (186) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top